APO Research

APO RESEARCH · REPORT

Chinese Medicine Injection for Bones and Muscles

Selected research

Market Structure

Global Chinese Medicine Injection for Bones and Muscles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Chinese Medicine Injection for Bones and Muscles market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chinese Medicine Injection for Bones and Muscles include Zhejiang Taikang Pharmaceutical, Xinjiang Yinduolan Pharmaceutical, Lonch Group, Hunan Zhengqing Pharmaceutical, Sinopharm Group Xinjiang Pharmaceutical, Guangdong Xinfeng Pharmaceutical and Anhui Fengyang Keyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Injection for Bones and Muscles market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Injection for Bones and Muscles and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Injection for Bones and Muscles sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Injection for Bones and Muscles market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Injection for Bones and Muscles Segment by Company

Zhejiang Taikang Pharmaceutical

Xinjiang Yinduolan Pharmaceutical

Lonch Group

Hunan Zhengqing Pharmaceutical

Sinopharm Group Xinjiang Pharmaceutical

Guangdong Xinfeng Pharmaceutical

Anhui Fengyang Keyuan Pharmaceutical

Chinese Medicine Injection for Bones and Muscles Segment by Type

Xuelian Injection

Wild Papaya Injection

Zhengqing Fengtongning Injection

Zushima Injection

Other

Chinese Medicine Injection for Bones and Muscles Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Chinese Medicine Injection for Bones and Muscles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection for Bones and Muscles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection for Bones and Muscles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection for Bones and Muscles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Injection for Bones and Muscles market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chinese Medicine Injection for Bones and Muscles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chinese Medicine Injection for Bones and Muscles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chinese Medicine Injection for Bones and Muscles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Injection for Bones and Muscles Industry Trends Table 2. Chinese Medicine Injection for Bones and Muscles Industry Drivers Table 3. Chinese Medicine Injection for Bones and Muscles Industry Opportunities and Challenges Table 4. Chinese Medicine Injection for Bones and Muscles Industry Restraints Table 5. Global Chinese Medicine Injection for Bones and Muscles Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chinese Medicine Injection for Bones and Muscles Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Manufacturers Table 9. Global Chinese Medicine Injection for Bones and Muscles Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Chinese Medicine Injection for Bones and Muscles Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chinese Medicine Injection for Bones and Muscles Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chinese Medicine Injection for Bones and Muscles Manufacturers, Product Type & Application Table 13. Global Chinese Medicine Injection for Bones and Muscles Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Injection for Bones and Muscles by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Xuelian Injection Table 17. Major Manufacturers of Wild Papaya Injection Table 18. Major Manufacturers of Zhengqing Fengtongning Injection Table 19. Major Manufacturers of Zushima Injection Table 20. Major Manufacturers of Other Table 21. Global Chinese Medicine Injection for Bones and Muscles Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Chinese Medicine Injection for Bones and Muscles Sales by Type (2021-2026) & (k units) Table 23. Global Chinese Medicine Injection for Bones and Muscles Sales by Type (2027-2032) & (k units) Table 24. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Type (2021-2026) Table 25. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Type (2027-2032) Table 26. Global Chinese Medicine Injection for Bones and Muscles Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Chinese Medicine Injection for Bones and Muscles Revenue by Type (2021-2026) & (k units) Table 28. Global Chinese Medicine Injection for Bones and Muscles Revenue by Type (2027-2032) & (k units) Table 29. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Type (2021-2026) Table 30. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Secondary Hospital Table 32. Major Manufacturers of Tertiary Hospital Table 33. Major Manufacturers of Other Table 34. Global Chinese Medicine Injection for Bones and Muscles Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Chinese Medicine Injection for Bones and Muscles Sales by Application (2021-2026) & (k units) Table 36. Global Chinese Medicine Injection for Bones and Muscles Sales by Application (2027-2032) & (k units) Table 37. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Application (2021-2026) Table 38. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Application (2027-2032) Table 39. Global Chinese Medicine Injection for Bones and Muscles Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Chinese Medicine Injection for Bones and Muscles Revenue by Application (2021-2026) & (k units) Table 41. Global Chinese Medicine Injection for Bones and Muscles Revenue by Application (2027-2032) & (k units) Table 42. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Application (2021-2026) Table 43. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Application (2027-2032) Table 44. Global Chinese Medicine Injection for Bones and Muscles Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2021-2026) & (k units) Table 46. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Region (2021-2026) Table 47. Global Chinese Medicine Injection for Bones and Muscles Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Chinese Medicine Injection for Bones and Muscles Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2026) & (k units) Table 51. North America Chinese Medicine Injection for Bones and Muscles Sales by Country (2027-2032) & (k units) Table 52. Europe Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2026) & (k units) Table 54. Europe Chinese Medicine Injection for Bones and Muscles Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales by Country (2027-2032) & (k units) Table 61. Global Chinese Medicine Injection for Bones and Muscles Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Chinese Medicine Injection for Bones and Muscles Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Chinese Medicine Injection for Bones and Muscles Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Region (2021-2026) Table 65. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Region (2027-2032) Table 66. Zhejiang Taikang Pharmaceutical Company Information Table 67. Zhejiang Taikang Pharmaceutical Business Overview Table 68. Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 70. Zhejiang Taikang Pharmaceutical Recent Development Table 71. Xinjiang Yinduolan Pharmaceutical Company Information Table 72. Xinjiang Yinduolan Pharmaceutical Business Overview Table 73. Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 75. Xinjiang Yinduolan Pharmaceutical Recent Development Table 76. Lonch Group Company Information Table 77. Lonch Group Business Overview Table 78. Lonch Group Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Lonch Group Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 80. Lonch Group Recent Development Table 81. Hunan Zhengqing Pharmaceutical Company Information Table 82. Hunan Zhengqing Pharmaceutical Business Overview Table 83. Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 85. Hunan Zhengqing Pharmaceutical Recent Development Table 86. Sinopharm Group Xinjiang Pharmaceutical Company Information Table 87. Sinopharm Group Xinjiang Pharmaceutical Business Overview Table 88. Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 90. Sinopharm Group Xinjiang Pharmaceutical Recent Development Table 91. Guangdong Xinfeng Pharmaceutical Company Information Table 92. Guangdong Xinfeng Pharmaceutical Business Overview Table 93. Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 95. Guangdong Xinfeng Pharmaceutical Recent Development Table 96. Anhui Fengyang Keyuan Pharmaceutical Company Information Table 97. Anhui Fengyang Keyuan Pharmaceutical Business Overview Table 98. Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 100. Anhui Fengyang Keyuan Pharmaceutical Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Chinese Medicine Injection for Bones and Muscles Distributors List Table 104. Chinese Medicine Injection for Bones and Muscles Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Chinese Medicine Injection for Bones and Muscles Product Image Figure 2. Global Chinese Medicine Injection for Bones and Muscles Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Injection for Bones and Muscles Market Size (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Injection for Bones and Muscles Sales (2021-2032) & (k units) Figure 5. Global Chinese Medicine Injection for Bones and Muscles Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Chinese Medicine Injection for Bones and Muscles Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Xuelian Injection Image Figure 9. Wild Papaya Injection Image Figure 10. Zhengqing Fengtongning Injection Image Figure 11. Zushima Injection Image Figure 12. Other Image Figure 13. Global Chinese Medicine Injection for Bones and Muscles Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Type (2021-2032) Figure 16. Global Chinese Medicine Injection for Bones and Muscles Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Type (2021-2032) Figure 19. Secondary Hospital Image Figure 20. Tertiary Hospital Image Figure 21. Other Image Figure 22. Global Chinese Medicine Injection for Bones and Muscles Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Application (2021-2032) Figure 25. Global Chinese Medicine Injection for Bones and Muscles Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Application (2021-2032) Figure 28. North America Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Chinese Medicine Injection for Bones and Muscles Sales Market Share by Country (2021-2032) Figure 30. U.S. Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Chinese Medicine Injection for Bones and Muscles Sales Market Share by Country (2021-2032) Figure 35. Germany Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales Market Share by Country (2021-2032) Figure 42. China Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales Market Share by Country (2021-2032) Figure 50. Brazil Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Chinese Medicine Injection for Bones and Muscles Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Chinese Medicine Injection for Bones and Muscles Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032) & (US$ Million) Figure 61. North America Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032) & (US$ Million) Figure 63. Europe Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Chinese Medicine Injection for Bones and Muscles Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Chinese Medicine Injection for Bones and Muscles Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Xuelian Injection
  • Wild Papaya Injection
  • Zhengqing Fengtongning Injection
  • Zushima Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • Zhejiang Taikang Pharmaceutical
  • Xinjiang Yinduolan Pharmaceutical
  • Lonch Group
  • Hunan Zhengqing Pharmaceutical
  • Sinopharm Group Xinjiang Pharmaceutical
  • Guangdong Xinfeng Pharmaceutical
  • Anhui Fengyang Keyuan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chinese Medicine Injection for Bones and Muscles Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chinese Medicine Injection for Bones and Muscles Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chinese Medicine Injection for Bones and Muscles Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chinese Medicine Injection for Bones and Muscles Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chinese Medicine Injection for Bones and Muscles Market Dynamics
  1. 2.1 Chinese Medicine Injection for Bones and Muscles Industry Trends
  2. 2.2 Chinese Medicine Injection for Bones and Muscles Industry Drivers
  3. 2.3 Chinese Medicine Injection for Bones and Muscles Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Injection for Bones and Muscles Industry Restraints
3 Chinese Medicine Injection for Bones and Muscles Market by Manufacturers
  1. 3.1 Global Chinese Medicine Injection for Bones and Muscles Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chinese Medicine Injection for Bones and Muscles Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chinese Medicine Injection for Bones and Muscles Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chinese Medicine Injection for Bones and Muscles Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chinese Medicine Injection for Bones and Muscles Manufacturers, Product Type & Application
  7. 3.7 Global Chinese Medicine Injection for Bones and Muscles Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chinese Medicine Injection for Bones and Muscles Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chinese Medicine Injection for Bones and Muscles Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chinese Medicine Injection for Bones and Muscles Tier 1, Tier 2, and Tier 3
4 Chinese Medicine Injection for Bones and Muscles Market by Type
  1. 4.1 Chinese Medicine Injection for Bones and Muscles Type Introduction
  2. 4.1.1 Xuelian Injection
  3. 4.1.2 Wild Papaya Injection
  4. 4.1.3 Zhengqing Fengtongning Injection
  5. 4.1.4 Zushima Injection
  6. 4.1.5 Other
  7. 4.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Type
  8. 4.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Type (2021-2032)
  10. 4.2.3 Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Type (2021-2032)
  11. 4.3 Global Chinese Medicine Injection for Bones and Muscles Revenue by Type
  12. 4.3.1 Global Chinese Medicine Injection for Bones and Muscles Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Chinese Medicine Injection for Bones and Muscles Revenue by Type (2021-2032)
  14. 4.3.3 Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Type (2021-2032)
5 Chinese Medicine Injection for Bones and Muscles Market by Application
  1. 5.1 Chinese Medicine Injection for Bones and Muscles Application Introduction
  2. 5.1.1 Secondary Hospital
  3. 5.1.2 Tertiary Hospital
  4. 5.1.3 Other
  5. 5.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Application
  6. 5.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Application (2021-2032)
  8. 5.2.3 Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Application (2021-2032)
  9. 5.3 Global Chinese Medicine Injection for Bones and Muscles Revenue by Application
  10. 5.3.1 Global Chinese Medicine Injection for Bones and Muscles Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Chinese Medicine Injection for Bones and Muscles Revenue by Application (2021-2032)
  12. 5.3.3 Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Application (2021-2032)
6 Global Chinese Medicine Injection for Bones and Muscles Sales by Region
  1. 6.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2021-2026)
  4. 6.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chinese Medicine Injection for Bones and Muscles Revenue by Region
  1. 7.1 Global Chinese Medicine Injection for Bones and Muscles Revenue by Region
  2. 7.1.1 Global Chinese Medicine Injection for Bones and Muscles Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chinese Medicine Injection for Bones and Muscles Revenue by Region (2021-2026)
  4. 7.1.3 Global Chinese Medicine Injection for Bones and Muscles Revenue by Region (2027-2032)
  5. 7.1.4 Global Chinese Medicine Injection for Bones and Muscles Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032)
  8. 7.2.2 North America Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032)
  11. 7.3.2 Europe Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chinese Medicine Injection for Bones and Muscles Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Taikang Pharmaceutical
  2. 8.1.1 Zhejiang Taikang Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Taikang Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  6. 8.1.5 Zhejiang Taikang Pharmaceutical Recent Developments
  7. 8.2 Xinjiang Yinduolan Pharmaceutical
  8. 8.2.1 Xinjiang Yinduolan Pharmaceutical Company Information
  9. 8.2.2 Xinjiang Yinduolan Pharmaceutical Business Overview
  10. 8.2.3 Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  12. 8.2.5 Xinjiang Yinduolan Pharmaceutical Recent Developments
  13. 8.3 Lonch Group
  14. 8.3.1 Lonch Group Company Information
  15. 8.3.2 Lonch Group Business Overview
  16. 8.3.3 Lonch Group Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lonch Group Chinese Medicine Injection for Bones and Muscles Product Portfolio
  18. 8.3.5 Lonch Group Recent Developments
  19. 8.4 Hunan Zhengqing Pharmaceutical
  20. 8.4.1 Hunan Zhengqing Pharmaceutical Company Information
  21. 8.4.2 Hunan Zhengqing Pharmaceutical Business Overview
  22. 8.4.3 Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  24. 8.4.5 Hunan Zhengqing Pharmaceutical Recent Developments
  25. 8.5 Sinopharm Group Xinjiang Pharmaceutical
  26. 8.5.1 Sinopharm Group Xinjiang Pharmaceutical Company Information
  27. 8.5.2 Sinopharm Group Xinjiang Pharmaceutical Business Overview
  28. 8.5.3 Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  30. 8.5.5 Sinopharm Group Xinjiang Pharmaceutical Recent Developments
  31. 8.6 Guangdong Xinfeng Pharmaceutical
  32. 8.6.1 Guangdong Xinfeng Pharmaceutical Company Information
  33. 8.6.2 Guangdong Xinfeng Pharmaceutical Business Overview
  34. 8.6.3 Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  36. 8.6.5 Guangdong Xinfeng Pharmaceutical Recent Developments
  37. 8.7 Anhui Fengyang Keyuan Pharmaceutical
  38. 8.7.1 Anhui Fengyang Keyuan Pharmaceutical Company Information
  39. 8.7.2 Anhui Fengyang Keyuan Pharmaceutical Business Overview
  40. 8.7.3 Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  42. 8.7.5 Anhui Fengyang Keyuan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Injection for Bones and Muscles Value Chain Analysis
  2. 9.1.1 Chinese Medicine Injection for Bones and Muscles Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Injection for Bones and Muscles Production Mode & Process
  6. 9.2 Chinese Medicine Injection for Bones and Muscles Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Injection for Bones and Muscles Distributors
  9. 9.2.3 Chinese Medicine Injection for Bones and Muscles Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research